Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: Are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

Radiotherapy and Oncology

Volumn 98, Issue 1, 2011, Pages 99-104

  Fraunholz, Ingeborg ^a   Rabeneck, Daniela ^a   Gerstein, Johanna ^a   Jäck, Katharina ^a   Haberl, Annette ^a   Weiss, Christian ^a   Rödel, Claus ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anal carcinoma; Chemoradiotherapy; Highly active antiretroviral therapy; Human immunodeficiency virus

Indexed keywords

ANTIRETROVIRUS AGENT; FLUOROURACIL; MITOMYCIN C;

ADULT; ANUS CARCINOMA; ANUS FISTULA; ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CHEMORADIOTHERAPY; CHRONIC DIARRHEA; CONTINUOUS INFUSION; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DRUG DOSE REDUCTION; FECES INCONTINENCE; FEMALE; FIBROSIS; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PERIANAL ABSCESS; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RADIATION ENTEROPATHY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY URGENCY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PATIENT COMPLIANCE;

EID: 78651366654     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.11.011     Document Type: Article

References (23)

1. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Co-ordinating committee on cancer research. Lancet 1996;348:1049-1054.
2. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049 (Pubitemid 27209535)
3. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539 (Pubitemid 26300120)
4. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial JAMA 299 2008 1914 1921
5. M. Chadha, E.A. Rosenblatt, and S. Malamud Squamous-cell carcinoma of the anus in HIV-positive patients Dis Colon Rectum 37 1994 861 865 (Pubitemid 24281918)
6. A.V. Peddada, D.E. Smith, and A.R. Rao Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal Int J Radiat Oncol Biol Phys 37 1997 1101 1105
7. J.H. Kim, B. Sarani, and B.A. Orkin HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients Dis Colon Rectum 44 2001 1496 1502 (Pubitemid 32952556)
8. R.J. Place, S.G. Gregorcyk, and P.J. Huber Outcome analysis of HIV-positive patients with anal squamous cell carcinoma Dis Colon Rectum 44 2001 506 512 (Pubitemid 32336424)
9. R. Hoffman, M.L. Welton, and B. Klencke The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer Int J Radiat Oncol Biol Phys 44 1999 127 131 (Pubitemid 29186199)
10. T. Antoniou, and A.L. Tseng Interactions between antiretrovirals and antineoplastic drug therapy Clin Pharmacokinet 44 2005 111 145 (Pubitemid 40188937)
11. F. Pajonk, J. Himmelsbach, and K. Riess The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells Cancer Res 62 2002 5230 5235 (Pubitemid 35024595)
12. J.A. Sparano, P.H. Wiernik, and X. Hu Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma Med Oncol 15 1998 50 57 (Pubitemid 28248300)
13. T.B. Brunner, M. Geiger, and G.G. Grabenbauer Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer J Clin Oncol 26 2008 2699 2706
14. E.Y. Chiao, T.P. Giordano, and P. Richardson Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era J Clin Oncol 26 2008 474 479 (Pubitemid 351171702)
15. A. Blazy, C. Hennequin, and J.M. Gornet Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy Dis Colon Rectum 48 2005 1176 1181 (Pubitemid 40897861)
16. S. Cleator, K. Fife, and M. Nelson Treatment of HIV-associated invasive anal cancer with combined chemoradiation Eur J Cancer 36 2000 754 758 (Pubitemid 30179747)
17. A. Wexler, A.M. Berson, and S.E. Goldstone Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy Dis Colon Rectum 51 2008 73 81
18. R.F. Stadler, S.G. Gregorcyk, and D.M. Euhus Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy Dis Colon Rectum 47 2004 1305 1309 (Pubitemid 39180205)
19. I. Fraunholz, C. Weiss, K. Eberlein, A. Haberl, and C. Rödel Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy Int J Radiat Oncol Biol Phys 76 2010 1425 1432
20. C. Oehler-Janne, F. Huguet, and S. Provencher HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy J Clin Oncol 26 2008 2550 2557
21. J.M. Holland, and P.S. Swift Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy Radiology 193 1994 251 254
22. Y. Seo, M.T. Kinsella, and H.L. Reynolds Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients Int J Radiat Oncol Biol Phys 75 2009 143 149
23. M.E. Hogg, D.A. Popowich, E.C. Wang, K.D. Kiel, S.J. Stryker, and A.L. Halverson HIV and anal cancer outcomes: a single institution's experience Dis Colon Rectum 52 2009 891 897